The Hugh Kaul Personalized Medicine Institute recently awarded two collaborative pilot implementation projects to advance precision medicine at UAB. David Geldmacher, M.D., professor in the Department of Neurology, will lead a project focused on using patient-specific genetic information to select medications to help attenuate behavioral and psychiatric symptoms in patients with dementia. Warner Huh, M.D., director of the Division of Gynecologic Oncology, and Rebecca Arend M.D., assistant professor in the Department of Obstetrics and Gynecology, will conduct molecular profiling on patients with recurrent ovarian cancer which may enable selection of more targeted treatment against the deadliest gynecologic cancer.